192 - An Update on COVID-19 Treatments: Monoclonal Antibodies, Convalescent Plasma, Remdesivir and More

COVID-19 mortality rates are falling and better treatments are one of the main reasons why. Dr. Arturo Casadevall returns to the podcast to talk with Stephanie Desmon about where we are with different treatments and their successes, ongoing clinical trials, why some treatments are harder than others to produce, and whether we'll continue to see investments in treatments when a vaccine is available.

KEYWORDS: COVID-19 therapy; vaccine authorization; immune response